According to Hoshida et al., S1 reflects TGF-β-mediated activation of the WNT signaling pathway, S2 is proliferative tumor with MYC and AKT activation, and S3 is well-differentiated tumors17. The gene discussed is TGFB1; the disease is neoplasm.